Literature DB >> 500197

Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis.

R Ramphal, R C Cogliano, J W Shands, P A Small.   

Abstract

This paper reports studies showing the effects of serum antibody upon influenza infection at two different sites: the trachea and lung. Tracheal desquamation, pulmonary consolidation, death, and virus shedding were examined after infection of mice with a lethal A/Port Chalmers/1/73 (H3N2) influenza virus. Immune serum administered intraperitoneally before infection prevented death and pulmonary consolidation and also significantly lowered lung virus shedding as compared with controls receiving normal serum. However, this protection did not extend to the ciliated epithelium of the trachea because serum antibody did not prevent desquamation of the trachea or significantly decrease viral yield from the trachea. These results indicate that serum antibody is protective against severe pulmonary parenchymal disease but not for disease of the ciliated epithelium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500197      PMCID: PMC414546          DOI: 10.1128/iai.25.3.992-997.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  COURSE OF A2 INFLUENZA IN INTRANASALLY INFECTED MICE EXAMINED BY THE FLUORESCENT ANTIBODY TECHNIQUE.

Authors:  P ALBRECHT; D BLASKOVIC; B STYK; M KOLLER
Journal:  Acta Virol       Date:  1963-09       Impact factor: 1.162

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Infection of the upper respiratory tract of mice with influenza A virus.

Authors:  T IIDA; F B BANG
Journal:  Am J Hyg       Date:  1963-03

4.  Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies.

Authors:  J J WALSH; L F DIETLEIN; F N LOW; G E BURCH; W J MOGABGAB
Journal:  Arch Intern Med       Date:  1961-09

5.  Air-borne influenza virus A infections in immunized animals.

Authors:  C G LOOSLI; D HAMRE; B S BERLIN
Journal:  Trans Assoc Am Physicians       Date:  1953

6.  Studies in experimental immunology of influenza. IV. The protective value of active immunization.

Authors:  S FAZEKAS de ST GROTH; M DONNELLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1950-01

7.  Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain.

Authors:  T W Hoskins; J R Davies; A Allchin; C L Miller; T M Pollock
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

8.  Immune response of the human respiratory tract. I. Immunoglobulin levels and influenza virus vaccine antibody response.

Authors:  R H Waldman; P F Jurgensen; G N Olsen; R Ganguly; J E Johnson
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

9.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

10.  Local and systemic immunity to influenza infections in ferrets.

Authors:  W H Barber; P A Small
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

View more
  30 in total

1.  Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection.

Authors:  B S Bender; M P Johnson; P A Small
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Protective effect of serum antibody on respiratory infection of influenza C virus in rats.

Authors:  K Takiguchi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice.

Authors:  M Tashiro; K Tobita; J T Seto; R Rott
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.

Authors:  N F Crum-Cianflone; G Collins; G Defang; E Iverson; L E Eberly; C Duplessis; J Maguire; A Ganesan; B K Agan; T Lalani; T Whitman; C Brandt; D Faix; P J Blair; T Burgess
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 5.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

6.  A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

Authors:  N L Davis; K W Brown; R E Johnston
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.

Authors:  R M Kinney; J J Esposito; J H Mathews; B J Johnson; J T Roehrig; A D Barrett; D W Trent
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

10.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.